NZ179080A - 1-methyl-4-(3-carboxy-10,11-dihydro-5h-dcibenzo(a,d)cyclohepten-5-ylidene)-piperidine,its esters,amides and n-oxide,and pharmaceutical compositions - Google Patents

1-methyl-4-(3-carboxy-10,11-dihydro-5h-dcibenzo(a,d)cyclohepten-5-ylidene)-piperidine,its esters,amides and n-oxide,and pharmaceutical compositions

Info

Publication number
NZ179080A
NZ179080A NZ179080A NZ17908075A NZ179080A NZ 179080 A NZ179080 A NZ 179080A NZ 179080 A NZ179080 A NZ 179080A NZ 17908075 A NZ17908075 A NZ 17908075A NZ 179080 A NZ179080 A NZ 179080A
Authority
NZ
New Zealand
Prior art keywords
dihydro
amides
esters
oxide
pharmaceutical compositions
Prior art date
Application number
NZ179080A
Inventor
D Remy
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NZ179080A publication Critical patent/NZ179080A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)

Abstract

10,11-Dihydro-3-carboxycyproheptadine and its esters, amides and N-oxide are disclosed to have pharmaceutical utility as appetite stimulants and as antihistaminic agents. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such, compounds; and methods of treatment comprising administering such compounds and compositions.
NZ179080A 1974-11-11 1975-10-28 1-methyl-4-(3-carboxy-10,11-dihydro-5h-dcibenzo(a,d)cyclohepten-5-ylidene)-piperidine,its esters,amides and n-oxide,and pharmaceutical compositions NZ179080A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52267674A 1974-11-11 1974-11-11
US56328575A 1975-03-28 1975-03-28

Publications (1)

Publication Number Publication Date
NZ179080A true NZ179080A (en) 1978-07-10

Family

ID=27060901

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ179080A NZ179080A (en) 1974-11-11 1975-10-28 1-methyl-4-(3-carboxy-10,11-dihydro-5h-dcibenzo(a,d)cyclohepten-5-ylidene)-piperidine,its esters,amides and n-oxide,and pharmaceutical compositions

Country Status (19)

Country Link
JP (1) JPS6011029B2 (en)
AR (1) AR211108A1 (en)
AT (1) AT352126B (en)
CA (1) CA1082177A (en)
CH (1) CH621114A5 (en)
DE (1) DE2550395C3 (en)
DK (1) DK474575A (en)
ES (1) ES442375A1 (en)
FI (1) FI59583C (en)
FR (1) FR2290203A1 (en)
IE (1) IE42220B1 (en)
IL (1) IL48365A (en)
LU (1) LU73771A1 (en)
NL (2) NL173398B (en)
NO (1) NO144422C (en)
NZ (1) NZ179080A (en)
PH (1) PH13443A (en)
SE (1) SE424990B (en)
YU (1) YU273475A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195091A (en) * 1978-11-15 1980-03-25 Merck & Co., Inc. Appetite stimulating pyrrolo[2,1-b][3]benzazepines
US4412999A (en) * 1982-04-14 1983-11-01 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same

Also Published As

Publication number Publication date
ES442375A1 (en) 1977-08-16
IL48365A (en) 1978-10-31
DE2550395A1 (en) 1976-05-13
CH621114A5 (en) 1981-01-15
FR2290203A1 (en) 1976-06-04
ATA843975A (en) 1979-02-15
NL173398C (en)
YU273475A (en) 1983-04-27
LU73771A1 (en) 1976-09-06
DE2550395B2 (en) 1978-11-30
IL48365A0 (en) 1975-12-31
PH13443A (en) 1980-04-23
NL173398B (en) 1983-08-16
SE7511792L (en) 1976-05-12
DE2550395C3 (en) 1979-08-09
JPS5170769A (en) 1976-06-18
FR2290203B1 (en) 1980-05-30
FI59583C (en) 1981-09-10
AT352126B (en) 1979-09-10
NO144422B (en) 1981-05-18
AU8605775A (en) 1977-05-05
DK474575A (en) 1976-05-12
FI752920A (en) 1976-05-12
FI59583B (en) 1981-05-29
CA1082177A (en) 1980-07-22
SE424990B (en) 1982-08-23
NO144422C (en) 1981-08-26
NL7512384A (en) 1976-05-13
NO753562L (en) 1976-05-12
IE42220B1 (en) 1980-07-02
IE42220L (en) 1976-05-11
AR211108A1 (en) 1977-10-31
JPS6011029B2 (en) 1985-03-22

Similar Documents

Publication Publication Date Title
NZ180096A (en) N-(4-piperidyl)-n-phenylamides,-amines and -carba-mates,and analgesic compositions
ES463633A1 (en) Piperidine derivatives
ES447803A2 (en) Plasminogen activator pharmaceutical compositions
ES435246A1 (en) Piperidine derivatives
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
IL56346A (en) N-substituted omega-aminoalkanoyl-omega-aminoalkanoic acids,process for their production as well as pharmaceutical compositions containing these compounds
ES8106891A1 (en) 2-Hydroxyalkyl-3,4,5,trihydroxy piperidines, processes for their preparation and their use as medicaments.
ES475633A1 (en) 1-N-substituted-4,6-di-O-(aminoglycosyl)-1,3-diamino-cyclitol derivatives, process for preparing them and medicaments containing them.
HU174927B (en) Process for producing 1-benzazoalkyl-4-substituted-piperidine derivatives and pharmaceutical compositions containing them as active agents
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
NZ179080A (en) 1-methyl-4-(3-carboxy-10,11-dihydro-5h-dcibenzo(a,d)cyclohepten-5-ylidene)-piperidine,its esters,amides and n-oxide,and pharmaceutical compositions
HU174010B (en) Process for producing 1-alkyl-2-bracket-phenoxymethyl-bracket closed-5-nitro-imidasoles and pharmaceutical compositions containing them as active agents
HU171120B (en) Process for producing 2-carbalkoxyamino-5-bracket-6-bracket closed-phenyl-sulphonyloxy-benzimidazole derivatives and anthelmintic compositions containing them as active agents
ES269442A1 (en) Lysine orotate
GB1512101A (en) Piperazinopyrimidines process for their preparation and use
HU174882B (en) Process for producing 1,12-methanooxymethano-indolo-square bracket-2,3-a-square bracket closed-quinolysine derivatives and pharmaceutical compositions containing them as active agents
HU174097B (en) Process for producing 3-amino-2-hydroxypropane-disubstituted phenolether derivatives and pharmaceutical compositions containing them as active agents
ES8100661A1 (en) Isoxazole derivative, preparation thereof and pharmaceutical compositions containing the same.
ES388822A1 (en) Biocidal composition and disinfecting method
HU167415B (en) Process for production of 1,4-dihydrolinolines and medical compositions containing them
ES390754A1 (en) 3-substituted-6-alkyl-2,3,6,9-tetrahydro-2,9-dioxothiazolo(5,4-f)-quinoline-8-carboxylic acids and methods for producing same
HU171537B (en) Process for producing new 5-butyl-pyridine-2-carboxylic esters, and pharmaceutical compositions containing them as active agent
IE42065L (en) Dibenzocycloheptenylidenepiperidine derivative.
GB878284A (en) 1-o-tolyloxyethyl-4-phenyl-piperidine
HU175697B (en) Process for producing beta-lactame-derivatives and pharmaceutical compositions containing them as active agents